# OnCo record callio-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/callio-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "callio-therapeutics" ;
  schema:name "Callio Therapeutics"@en ;
  schema:description "Callio Therapeutics makes antibodies that carry two different cancer-killing drugs at once to HER2-positive tumours, to stop cancers escaping treatment. Its first medicine entered human trials in 2026."@en ;
  schema:url <https://onco.cc/companies/callio-therapeutics/>, <https://calliotx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://calliotx.com/>, <https://www.prnewswire.com/news-releases/callio-therapeutics-launches-with-us187-million-series-a-to-advance-multi-payload-antibody-drug-conjugate-platform-through-clinical-proof-of-concept-302388161.html>, <https://calliotx.com/news/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/dual-payload-adc/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/atr/> ;
  onco:trials <https://onco.cc/trials/nct07300943/> .